Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 2
1(50.0%)
2Total
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03272724Recruiting

French National Observatory on Infective Endocarditis

Role: collaborator

NCT06297252Not ApplicableRecruiting

Prevalence of Psychiatric Disorders During Pregnancy at 2nd Trimester Ultrasound: a Feasibility Study in the General Population

Role: collaborator

NCT03187886Terminated

Use Lay Language. CAA-ri : a Series of 28 Patients

Role: collaborator

NCT02385903Phase 2Terminated

Randomized Controlled Trial on the Use of Flammacerium in Necrotic Arterial Wounds of the Lower Limb Versus Standard Treatment

Role: collaborator

NCT00501423Completed

Antiplatelet Drug Resistances and Ischemic Events

Role: collaborator

All 5 trials loaded